Drug recall · November 27, 2024
BEVACIZUMAB recall
Why: Lack of Sterility Assurance
Class II: could cause temporary or reversible health problems; serious harm is remote.
The recall
- Product
BEVACIZUMAB (AVASTIN)1.25mg/0.05mL, Sterile Injection, 0.5 mL Single-Dose Syringe, Rx Only, Repackaged by: Medivant Healthcare: 24416 N 19th Ave, Phoenix, AZ, NDC 81483-0041-1
- Lots / codes
Lot #: D24005, Exp. Date 20 February 2025; D24006, Exp. Date 21 February 2025; D24007, Exp. Date 22 February 2025; D24008, Exp. Date 19 March 2025; D24009, Exp. Date 20 March 2025; D24012, Exp. Date 25 April 2025.
- Quantity
- 27,560 Syringes
- Company
- Tailstorm Health INC, Phoenix, AZ
- Distribution
- Nationwide Within U.S.
- Initiated
- November 6, 2024 · Voluntary: Firm initiated
- Classified
- November 18, 2024
- Reported
- November 27, 2024
- Ended
- March 28, 2025
- How notified
- Letter
If you have this product
- Check the lot number on your package against the lots above. Only those lots are recalled.
- Don't stop a prescription medicine on your own. Call your pharmacy - they can swap it for an unaffected lot or another maker.
- Felt unwell? Contact your doctor, and report it to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
- Return or dispose of recalled product as the company or your pharmacy advises.
Questions about this recall
No comments yet. Questions, tips, what worked for you - start the conversation.